Nurse-led phone support after emergency visits for people with Alzheimer's
Nurse Led Telephonic Care
Nurses will call people with Alzheimer's disease and their caregivers after emergency department visits to help manage symptoms, plan care, and connect them with services.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11179237 on NIH RePORTER |
What this research studies
If you or a loved one with Alzheimer's go to the emergency department, a nurse will follow up by phone to review symptoms, medications, advance care planning, and home supports. The project uses an evidence-based program called Aliviado Dementia Care—Telephonic Edition delivered by an interdisciplinary nursing team. It is being tested as a large, real-world pragmatic effort triggered by ED visits and focused on people with serious illness and their care partners. The goal is to embed this phone-based transitional and palliative care into routine care to reduce repeat ED visits and improve equity of access.
Who could benefit from this research
Good fit: People living with Alzheimer’s disease or related dementias who recently visited an emergency department, especially those with serious illness or high caregiver strain, are the ideal candidates.
Not a fit: People without AD/ADRD, those who have not had a recent ED visit, or those already receiving intensive home or palliative programs may not be eligible or likely to benefit.
Why it matters
Potential benefit: If successful, this approach could reduce unnecessary emergency visits, improve symptom and caregiver support, and connect more people to home-based and palliative services.
How similar studies have performed: Prior nurse-led telephonic transitional and palliative programs have lowered ED visits and improved outcomes in palliative and earlier-stage dementia groups, but using ED-triggered telephonic care for seriously ill AD/ADRD patients is less tested.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Brody, Abraham Aizer — New York University School of Medicine
- Study coordinator: Brody, Abraham Aizer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.